Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -21.58% | -23.60% | -27.98% | -17.73% | -8.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.58% | -23.60% | -27.98% | -17.73% | -8.32% |
| Cost of Revenue | 5.38% | 5.41% | 1.96% | 1.06% | -0.75% |
| Gross Profit | -32.12% | -34.31% | -38.46% | -24.31% | -10.98% |
| SG&A Expenses | -30.93% | -30.57% | -32.60% | -25.23% | -18.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -69.85% | -108.53% | -146.44% | 4.79% | 60.19% |
| Total Operating Expenses | -17.74% | -21.76% | -28.01% | -19.68% | -12.15% |
| Operating Income | 6.26% | 16.65% | 28.07% | 24.67% | 21.90% |
| Income Before Tax | -32.21% | -23.42% | -11.71% | 2.00% | 16.30% |
| Income Tax Expenses | -- | 0.00% | 100.00% | 100.00% | 100.00% |
| Earnings from Continuing Operations | -32.11% | -23.42% | -11.79% | 1.73% | 15.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.11% | -23.42% | -11.79% | 1.73% | 15.90% |
| EBIT | 6.26% | 16.65% | 28.07% | 24.67% | 21.90% |
| EBITDA | 9.68% | 20.27% | 31.58% | 25.30% | 19.45% |
| EPS Basic | 44.44% | 31.58% | 23.81% | 22.73% | 21.74% |
| Normalized Basic EPS | 66.67% | 53.85% | 42.86% | 28.57% | 14.29% |
| EPS Diluted | 44.44% | 31.58% | 23.81% | 22.73% | 21.74% |
| Normalized Diluted EPS | 66.67% | 53.85% | 42.86% | 28.57% | 14.29% |
| Average Basic Shares Outstanding | 153.28% | 113.25% | 72.32% | 43.28% | 11.60% |
| Average Diluted Shares Outstanding | 153.28% | 113.25% | 72.32% | 43.28% | 11.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
